Drugs / Casein glycomacropeptide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01534312 | Jan 2012 → Sep 2014 | ulcerative colitis | University of Aarhus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Casein glycomacropeptide | “Casein glycomacropeptide purified powder dissolved in 300 ML water once daily” NCT01534312 ↗ |
| Modality | Protein / enzyme biologic | “CGMP protein” NCT01534312 ↗ |
| Route | Oral | “orally administered CGMP” NCT01534312 ↗ |